Bridging the transition from hospital to home: Effects of the VITAL Telehealth Program on recovery for CABG patients and their caregivers

ISRCTN ISRCTN77474147
DOI https://doi.org/10.1186/ISRCTN77474147
Secondary identifying numbers AØ6-B22-04A
Submission date
06/09/2005
Registration date
13/09/2005
Last edited
04/08/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Mrs Lisa Keeping
Scientific

54 Clipper Passage
Saint John, New Brunswick
E2K0A9
Canada

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Scientific title
Study objectives1. CABG patients who participate in the VITAL program will have a significantly greater decrease in anxiety between entry into the program and at 2 weeks after program completion as compared to CABG patients who receive usual care.
2. Caregivers of CABG patients who participate in the VITAL program will have a significantly greater decrease in anxiety between entry into the program and at 2 weeks after program completion as compared to caregivers of CABG patients who receive usual care.
Ethics approval(s)McGill University, Montreal QC and Atlantic Health Sciences Corporation, Saint John NB
Health condition(s) or problem(s) studiedRecovery from coronary artery bypass graft surgery
InterventionParticipants are randomly assigned to receive usual follow-up care or follow-up care with telehealth equipment. Patients and their caregivers in both groups receive all the usual cardiac teaching that is available during hospitalization. This consists of cardiac instruction from a multidisciplinary health care team on the day of admission to hospital, and on the second, third and fourth post-operative days. Patients are advised to follow-up with their family physician one week after discharge and then to return for a 6 week appointment with the cardiac surgeon.
Caregivers of patients who are assigned to receive follow-up with the telehealth equipment are also provided with two instructional sessions post-operatively and this then enables them to take the equipment home for one week. Having the telehealth equipment at home allows for daily audio-video visits between a patient’s home and the hospital. These daily sessions last approximately 30 minutes each.
Intervention typeProcedure/Surgery
Primary outcome measureThe 20-item State Anxiety Inventory (S-STAI) administered by telephone pre-operatively at baseline and at 5 days and 3 weeks after discharge
Secondary outcome measures1. Center for Epidemiologic Studies Depression Scale -10 (CESD-10) administered pre-operatively at baseline and at 5 days and 3 weeks after discharge
2. Health Care Utilization data collected at 5 days and 3 weeks after discharge
Overall study start date03/01/2005
Completion date30/04/2007

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants174
Key inclusion criteria1. The patient is undergoing first-time CABG surgery
2. The patient is hospitalized and waiting for CABG surgery, or is admitted to hospital for surgery after being on the cardiac wait list
3. There is a caregiver available and present on admission and/or during the patient’s hospitalization
4. There is a telephone in the home
5. There is a grounded electrical outlet, or three-prong plug outlet, in the home
6. The patient and caregiver speak and understand English and are cognitively able to participate in the interviews
7. Both the patient and caregiver will be likely to be able to adhere with the VITAL program
8. The patient and caregiver both consent to participate
Key exclusion criteria1. Patient is scheduled for valve replacement surgery
2. An attending physician believes it is necessary for a patient to have the VITAL program upon discharge.
Date of first enrolment03/01/2005
Date of final enrolment30/04/2007

Locations

Countries of recruitment

  • Canada

Study participating centre

54 Clipper Passage
Saint John, New Brunswick
E2K0A9
Canada

Sponsor information

McGill University (Canada)
University/education

3506 University Street
School of Nursing
Montreal QC
H3A2A7
Canada

Website http://www.nursing.mcgill.ca/
ROR logo "ROR" https://ror.org/01pxwe438

Funders

Funder type

University/education

Heart & Stroke Foundation of Canada Fellowship

No information available

McGill University

No information available

Groupe de recherche interuniversitaire

No information available

en soins infirmiers de Montréal (GRISIM) Fellowship

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan